United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.
“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.
“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.
SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.
I believe the next QR is likely to be out in abt a month's time from now. Perhaps another record breaking one judging from the huge volume transacted yesterday. This stock is definitely fundamentally stable and safe to hold on to...
It has never dropped below the RM1 level over the past three month period (since 7Oct2020)...and it seems to me that probably some funds have been quietly collecting these shares all this while.
1. Stable business model and stable growth 2. Growth comes from recently appointed central region distribution for Shell Lubricants on top of existing eastern and northern region distribution. 3. Dividend: Look at the dividend payout by Samchem. Earn more, pay out more. 4. Will benefit from USD depreciation as Samchem import from oversea 5. Low valuation
I always top up after a share breaks new high rather than before it happens. Believe me it works most of the time from my experience. You don't mind paying a bit more after the share increases a lot. For example if Samchem worth RM 3 after a year, a few cents differences is nothing anymore.
Yes...another record breaking QR. Samchem deserves a better share price than the current one at today closing (1.46). If based upon the average PE of KLSE of around 15, Samchem price level or fair value shud be way above 2.20.........
Samchem this QR is definately one of the excellent results among all the QR that released recently. Profit growth is superb and able to justify the share price increase (Not like most of the tech company that reported lower than expected profit growth qoq but share price increase substantially)
1. Yoy growth 160.9%, qoq growth 89.5% 2. Good result due to increase in selling price, margin expansion (net profit margin increase from range 1-2% to 3-6% recently) and finance cost reduction. 3. There is one off item of RM3.6m provision of doubtful debt. Samchem could report higher profit if this not happen 4. Declare 2 cents dividend 5. Low forward PE
This company is really in low profile and just focus on its business and will reward its shareholder in dividend. Earn more, pay out more to shareholders.
I also think that the good performance was partly due to weak USD bcz Samchem import from oversea. If USD weaken further, Samchem is likely to benefit. Also, most of the countries are starting to recover from covid and this will increase the demand for chemical slowly.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
NPRA1985
3,415 posts
Posted by NPRA1985 > 2020-12-09 22:52 | Report Abuse
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c